EP300 and colorectal carcinoma: Hence, our data indicate a novel mechanism, in which SEMA3B‐AS1 promotes SEMA3B expression through epigenetic regulation and suggest a crucial role of the SEMA3B‐AS1/EP300/SEMA3B pathway in CRC progression.